Source:http://linkedlifedata.com/resource/pubmed/id/11393754
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2001-6-6
|
pubmed:abstractText |
Astatine-211 was produced via the 209Bi(alpha,2n) 211At reaction. The radionuclide was isolated with a novel procedure employing dry-distillation of the irradiated target material. The astatine was condensed as a dry residue in a PEEK-capillary cryotrap. Distillation was completed within 1-2 min with isolation yields of 92 +/- 3%. Subsequent work-up of the nuclide resulted in final recovery yields of 79 +/- 3%.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0969-8043
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
55
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
157-60
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading | |
pubmed:year |
2001
|
pubmed:articleTitle |
Dry-distillation of astatine-211 from irradiated bismuth targets: a time-saving procedure with high recovery yields.
|
pubmed:affiliation |
Department of Radiation Physics, Göteborg University, Sahlgrenska University Hospital, Sweden. sture.lindegren@radfys.gu.se
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|